scispace - formally typeset
Q

Qian Wang

Researcher at Wuhan University

Publications -  3167
Citations -  88383

Qian Wang is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 108, co-authored 2148 publications receiving 65557 citations. Previous affiliations of Qian Wang include The Wallace H. Coulter Department of Biomedical Engineering & Yale University.

Papers
More filters
Journal ArticleDOI

Enabling Public Auditability and Data Dynamics for Storage Security in Cloud Computing

TL;DR: To achieve efficient data dynamics, the existing proof of storage models are improved by manipulating the classic Merkle Hash Tree construction for block tag authentication, and an elegant verification scheme is constructed for the seamless integration of these two salient features in the protocol design.
Proceedings ArticleDOI

Privacy-Preserving Public Auditing for Data Storage Security in Cloud Computing

TL;DR: This paper utilize and uniquely combine the public key based homomorphic authenticator with random masking to achieve the privacy-preserving public cloud data auditing system, which meets all above requirements.
Posted ContentDOI

Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, Progression Assessment, and Overall Survival Prediction in the BRATS Challenge

Spyridon Bakas, +438 more
TL;DR: This study assesses the state-of-the-art machine learning methods used for brain tumor image analysis in mpMRI scans, during the last seven instances of the International Brain Tumor Segmentation (BraTS) challenge, i.e., 2012-2018, and investigates the challenge of identifying the best ML algorithms for each of these tasks.
Journal ArticleDOI

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.

TL;DR: The clinical and immunological characteristics of severe patients, and the current evidence and share the experience in anti-inflammation treatment of patients with severe COVID-19 that may have an impaired immune system are discussed.